Filmmaker Karan Johar has always been vocal about his body image issues, and in a new podcast, he has opened up about ...

Novo Nordisk now expects sales to grow 13% to 21% in constant currencies this year, from 16% to 24% previously. Operating profit should grow 16% to 24% compared with a previous target of 19% to 27%.

Karan Johar has addressed ongoing speculation about his dramatic weight loss, firmly denying the use of weight-loss drugs ...

On the professional front, Gautami Kapoor was recently seen in Gyaarah Gyaarah, a thrilling adaptation of the popular Korean drama Signal. The series captivated audiences with its gripping storyline ...

The company has seen sales hit by alternative compounded versions of its blockbuster weight-loss and diabetes drugs, ...

In an interview, Karan Johar denied using the drug Ozempic for weight loss, and joked that he'd have found a way to monetise ...

Karan Johar has grown tired of people asking if used Ozempic or Mounjaro for his weight loss, and he's set the record ...

Karan Johar's recent physical transformation sparked speculation about the use of Ozempic, a popular weight-loss drug.

Over last few months, the airport looks, red carpet events or ramp walks have all pointed out towards filmmaker Karan Johars ...

The weight loss company will focus on its transition into a telehealth service that helps users get prescriptions for drugs ...

Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in ...

(Reuters) - WW International, formerly known as WeightWatchers, said it plans to file for Chapter 11 bankruptcy protection on Tuesday, as the surging popularity of obesity drugs such as Ozempic and ...